Fertility Fact SheetAs a leader in fertility health, EMD Serono, Inc. is dedicated to providing patient-friendly, innovative products that help
treat infertility.
The fact sheet talks about our marketed fertility products, and our patient support program, Fertility LifeLines.
Metabolic Endocrinology Fact SheetEMD Serono, Inc. is the only company with growth hormone approved for two clearly distinct diseases: growth hormone deficiency
and HIV-associated wasting.
The fact sheet talks about our marketed products, as well as needle and needle-free options.
Neurodegenerative Diseases Fact SheetOur neurodegenerative disease franchise is the company’s largest, led by our flagship product, Rebif® (interferon beta-1a)
for relapsing forms of multiple sclerosis (MS). We also have potential therapies for neurodegenerative diseases in development
including cladribine tablets, and safinamide.
The fact sheet talks about our products and pipeline, as well as our patient support program, MS LifeLines.
Oncology Fact SheetEMD Serono, Inc. is growing its presence in oncology in the US, with a focus on developing potentially novel first-in-class
therapies specifically targeting tumor cells.
The fact sheet talks about our research focus and key product candidates.
Patient Commitment Fact SheetEMD Serono, Inc. focuses on providing people with products that impact their lives, while offering unparalleled patient support
systems across all of our therapeutic areas.
The fact sheet talks about our free educational resources, reimbursement information, patient assistance programs, as well
as our unique product delivery systems.